Preclinical Investigation of Tian-Zhi-Kang as a Candidate Chemotherapeutic Agent

Grants and Contracts Details

StatusActive
Effective start/end date10/1/209/30/22

Funding

  • Hunan Yujing Bio-tech Co LTD: $319,138.00